Keya Medical is a global medical technology company specializing in deep learning–driven solutions for disease diagnosis and treatment. Its flagship product, DEEPVESSEL FFR, is an AI-powered, non-invasive CT-based fractional flow reserve (FFR) analysis. FDA-cleared, CE-marked, and NMPA-approved, DEEPVESSEL FFR utilizes advanced deep learning algorithms to provide physiological functional assessments of the coronary arteries from standard coronary CT angiography (CCTA), enabling clinicians to diagnose and manage coronary artery disease accurately.